Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · IEX Real-Time Price · USD
+0.440 (11.55%)
At close: Jul 16, 2024, 4:00 PM
+0.050 (1.18%)
After-hours: Jul 16, 2024, 7:56 PM EDT

Revance Therapeutics Statistics

Total Valuation

RVNC has a market cap or net worth of $443.90 million. The enterprise value is $642.06 million.

Market Cap 443.90M
Enterprise Value 642.06M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

RVNC has 104.45 million shares outstanding. The number of shares has increased by 13.29% in one year.

Shares Outstanding 104.45M
Shares Change (YoY) +13.29%
Shares Change (QoQ) +5.72%
Owned by Insiders (%) 8.55%
Owned by Institutions (%) 86.42%
Float 83.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.88
Forward PS 1.43
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.71
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.37

Current Ratio 5.37
Quick Ratio 4.46
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -14.76

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -60.00%
Return on Capital (ROIC) -81.03%
Revenue Per Employee $396,390
Profits Per Employee -$531,566
Employee Count 597
Asset Turnover 0.45
Inventory Turnover 1.87


In the past 12 months, RVNC has paid $300,000 in taxes.

Income Tax 300,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.92% in the last 52 weeks. The beta is 0.98, so RVNC's price volatility has been similar to the market average.

Beta (5Y) 0.98
52-Week Price Change -80.92%
50-Day Moving Average 3.05
200-Day Moving Average 5.75
Relative Strength Index (RSI) 77.86
Average Volume (20 Days) 1,913,885

Short Selling Information

The latest short interest is 15.19 million, so 14.55% of the outstanding shares have been sold short.

Short Interest 15.19M
Short Previous Month 14.35M
Short % of Shares Out 14.55%
Short % of Float 18.16%
Short Ratio (days to cover) 8.42

Income Statement

In the last 12 months, RVNC had revenue of $236.65 million and -$317.35 million in losses. Loss per share was -$3.64.

Revenue 236.65M
Gross Profit 163.54M
Operating Income -305.57M
Pretax Income -317.05M
Net Income -317.35M
EBITDA -287.87M
EBIT -296.93M
Loss Per Share -$3.64
Full Income Statement

Balance Sheet

The company has $277.62 million in cash and $475.78 million in debt, giving a net cash position of -$198.16 million or -$1.90 per share.

Cash & Cash Equivalents 277.62M
Total Debt 475.78M
Net Cash -198.16M
Net Cash Per Share -$1.90
Equity (Book Value) -98.67M
Book Value Per Share -0.94
Working Capital 300.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$213.01 million and capital expenditures -$7.73 million, giving a free cash flow of -$220.74 million.

Operating Cash Flow -213.01M
Capital Expenditures -7.73M
Free Cash Flow -220.74M
FCF Per Share -$2.40
Full Cash Flow Statement


Gross margin is 69.11%, with operating and profit margins of -129.13% and -134.10%.

Gross Margin 69.11%
Operating Margin -129.13%
Pretax Margin -133.97%
Profit Margin -134.10%
EBITDA Margin -121.65%
EBIT Margin -125.47%
FCF Margin -93.28%

Dividends & Yields

RVNC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.29%
Shareholder Yield -13.29%
Earnings Yield -71.49%
FCF Yield -49.73%
Dividend Details

Analyst Forecast

The average price target for RVNC is $12.00, which is 182.35% higher than the current price. The consensus rating is "Buy".

Price Target $12.00
Price Target Difference 182.35%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 25.85%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


RVNC has an Altman Z-Score of -6.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.19
Piotroski F-Score 4